RADX biotech catalysts & pipeline

RADIOPHARM THERANOSTICS LTD · Data as of 2026-10-25

Upcoming catalysts

Betabart (RV-01) — Initial data

2026

We remain focused on enrolling patients in the current cohort and look forward to reporting initial clinical data later this year,

Source filing

RAD402 — Initial data

2H 2026

On track to share data from first two dose levels in 2H 2026

Source filing

RAD101 — Conference presentation

Nov 12–Nov 15

positive data from an interim analysis of the Company's Phase 2b imaging clinical trial (NCT06777433) of 18F-RAD101 (RAD101) in participants with suspected recurrent brain metastases from solid tumors has been selected for a late-breaking oral presentation at the 31 st Annual Meeting of the Society of Neuro-Oncology (SNO26), taking place from November 12-15, 2026 in Philadelphia.

Source filing

Explore the free biotech catalyst calendar